Perfusion Systems Market Share & Size | Industry Growth 2027
The Perfusion Systems market was valued at US$ 1,044.75 million in 2018, it is expected to grow at a CAGR of 3.8% from 2019 to 2027.
Perfusion is the passage of fluid through the circulatory system or lymphatic system to an organ or a tissue, usually referring to the delivery of blood to a capillary bed in tissue. Perfusion is measured as the rate at which blood is delivered to tissue, or volume of blood per unit time (blood flow) per unit tissue mass. During major surgery, perfusion must be maintained and managed by the health professionals involved, rather than left to the body's homeostasis alone. The growth of the Perfusion Systems market is attributed to the rising prevalence of cardiovascular diseases, significant growth of pharmaceutical and biotechnology industries, rising need for the organ transplantation and rising cell based research activities play vital role in the growth of the perfusion systems market. However, the challenges such as expensive organ transplant surgeries and limited numbers of donors for organ transplant surgeries are likely to impact the growth of the market in the forecast period. On the other hand, technological development from emerging nations hold a significant opportunity for the market growth in the coming years.
The Perfusion Systems market is expected to witness substantial growth post-pandemic. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the COVID-19 pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increased demand for invitro diagnostic products and rising research and development activities worldwide. However, the medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out and delayed or prolonged equipment procurement. Additionally, virtual consultations by healthcare professionals are expected to become the mainstream care delivery model post-pandemic. With telehealth transforming care delivery, digital health will continue to thrive in coming years. In addition, disrupted clinical trials and the subsequent delay in drug launches is also expected to pave the way for entirely virtual trials in the future. New technologies such as mRNA is expected to emerge and shift the pharmaceutical industry and market is also expected to witness more vertical integration and joint ventures in coming years.
Market Insights
Growing Applications of Perfusion Systems in Healthcare to Drive Perfusion Systems Market Growth
Cardiovascular diseases (CVDs) are the disorders of the heart and blood vessels and include cerebrovascular disease, coronary heart disease, rheumatic heart disease and other conditions. Some of the major factors which leads to the death and difficulties are use of tobacco, unhealthy diet, and physical inactivity which increases the risk of heart attacks and strokes. CVDs are the leading cause of death across the globe, it affects more people as compared to any other disease. Other than the lifestyle and habit older people are more prone to the cardiovascular diseases. The ageing population commonly show the structural and functional alteration of vessels accumulation through their life. Thus it increases the risk of developing cardiovascular diseases.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Perfusion Systems Market: Strategic Insights
Market Size Value in US$ 1,044.75 Million in 2018 Market Size Value by US$ 1,442.28 Million by 2027 Growth rate CAGR of 3.8% from 2019-2027 Forecast Period 2019-2027 Base Year 2019
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Perfusion Systems Market: Strategic Insights
| Market Size Value in | US$ 1,044.75 Million in 2018 |
| Market Size Value by | US$ 1,442.28 Million by 2027 |
| Growth rate | CAGR of 3.8% from 2019-2027 |
| Forecast Period | 2019-2027 |
| Base Year | 2019 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
The prevalence of the cardiovascular diseases is increasing across the world. The key factors that lead to the occurrence of cardiovascular diseases among the population. Cardiovascular diseases are major cause of the deaths across the world. As per the American College of Cardiology, it is stated that CVD contributes nearly 800,000deaths in the US, which is approximately to one out every three deaths. The coronary heart disease (CHD) contributes to the majority of CVD deaths which is further followed by stroke and heart failure. Nearly over 90 million Americans get diagnosed with CVD. In addition, it is stated that at a global level cardiovascular diseases contributes around 31% of all deaths and is expected that the cost of the CVD will be approximately to US$ 1,044 billion by 2030.
In Europe, every year cardiovascular disease (CVD) causes 3.9 million deaths and more than 1.8 million deaths in the European Union (EU). The CVD accounts for 45.0% of all deaths in Europe and 37.0% of all deaths in the EU. CVD is the major reason of the death in men and women in all countries. Therefore, the perfusion systems are required to bypasses the function of the heart and lung during the heart surgery and helps in maintaining the circulation of blood and the oxygen content of the body. Hence, owing to the rising prevalence of cardiovascular diseases in the regions and in various countries, the need of perfusion systems for the treatment of the CVD are likely to increases the market during the forecast period.
The perfusion systems market is also driven by the significant growth of pharmaceutical and biotechnology industry. In the past few years, pharmaceutical and biotechnological industry has been developing at an unusually rapid pace. The rise in the prevalence of the chronic and acute diseases are alarming the need of the medicines, therapeutic, vaccines, antibiotics and others. The technological advancements have assisted the manufacturers with ease in technique to enhance their production. These manufacturers along with their alliance with the contract research organizations (CROs) are confronting to the enormous healthcare challenges through new medicines, therapy forms, progressing digitalization and constantly changing the regulations. In addition, the rise in the geriatric population is leading to rising healthcare conditions. As per the World Health Organization, the global population is increasing by 1.24% per annum leading to rise in number of people in the geriatric class.
The WHO also suggests that the proportion of people aged 65 to 80 will rise to 28% in 2030, compared to 22% in 2000. Moreover, according to a survey report published by Torreya Economical Model 2017, pharmaceutical industry is 30% larger than its previous estimations till 2017 and contributes to one of the top five industries increasing global economy value.
Furthermore, the increase in the start-up companies for the pharmaceutical, biopharmaceutical and biotechnology are growing with a good number across the world. These companies are developing innovative drug and therapeutic products and been supported by the respective governments of the countries. Therefore, enormous growth in the production of the medicine and other therapeutic products is shown by the start-up and established players. The production of the medicines and therapeutic products requires the perfusion systems and perfusion systems to produce the raw materials obtained by the biological source. The biotechnology companies are also engaged in the production of the raw materials for the agriculture, food and beverage and other sectors. In contrast to the pharmaceutical industry, biotechnology companies require perfusion systems more. Hence, owing to these factors the market for the perfusion systems is likely to propel in the coming forecast years.
Organ transplantation is a surgical process done when a patient’s organ has stopped functioning completely. The organ transplant is commonly done for the organs such as heart, liver and kidney. However, the rising cases of the chronic diseases are leading to the need of the transplantation for the other organs such as lung, pancreases, cornea, and vascular tissues among others. Organ transplantation is considered as one of the great advanced in the modern medical industry.
The rise in the chronic diseases that causes damages the functions heart, lung, liver, kidney and other organs are leading to the increasing number of the organ transplantation. The organ transplantation surgeries are rising across the world. For instance, in Spain, approximately 5,260 transplant surgeries were performed, among which nearly 3,200 were kidney transplant and around 1,200 were liver transplant surgeries. The number of heart transplant surgeries were approximately 300 and lung were nearly 360. The public-private partnership in assistance with the transplant coordinators has enormously contributed to the improvement of the organ transplantation. The developing and developed countries have shown good numbers of the organ transplantation surgeries. For instance, developing countries like India and Singapore are emerging as medical tourism destination in the Asia Pacific region. The countries are growing in terms of offering better and advanced medical treatments.
As per the National Chronic Kidney Disease fact sheet 2017, states that approximately, 30 million people in US are estimated to have chronic kidney diseases. Similarly, according to the National Institute id Diabetes and Digestive and Kidney Diseases states that nearly 661,000 Americans have kidney failure among these nearly, 468,000 patients are taking dialysis, and approximately 193,000 have undergone kidney transplantation. Therefore, the increasing incidences are likely to grow more needs for the kidney transplantation in the coming years. Likewise, it is estimated that the growing numbers of the heart diseases are also responsible to drive the market in coming futures. Thus, the rising need for the organ transplantation is among the key driving factors for the perfusion systems market.
The rise in the chronic diseases, advantages of the applications of biotechnology are growing the extensive cell based research activities. The cell based assays assists in understanding the challenges of biology of the living organisms. The study and research helps to understand the disease processes and its complexity. The cell based assays helps in the understanding the aspects such as cell signaling, proliferation, apoptosis, cellular genetics, neurology, cancer and more.
The cell based assays are extensively carried out in pharmaceutical, biotechnology industries, research institutes and academics research institutes. The pharmaceutical and biopharmaceutical industries need to efficiently commercialize the drug. Therefore, cell based assays in the pharmaceutical and biotechnology industry are the driving factor for the growth of the perfusion systems.
The cell based assays are also extensively carried out by the contract research organization for the clinical trial studies and other processes. The chronic diseases such as cancer and other genetic related studies are enforcing for the cell based studies. For instance, Charles River offers services for the human primary cell based assays and according to an article published by the company states that the development in the cell based assays are likely to continue growing in the future. It states that the cell based assays are helpful in the drug discovery as the in vitro to in vivo correlation plays a vital role in the development of a drug. Thus, the increasing cell based research activities are likely to drive the perfusion systems in the forecast period.
Type-Based Insights
In terms of type, the Perfusion Systems market is segmented into microfluidic perfusion systems, small-mammal organ perfusion systems, bioreactor perfusion systems, gravity or pressure-driven perfusion systems. In 2018, the bioreactors perfusion systems segment held a largest market share of 44.3% of the perfusion systems market, by type.
Component-Based Insights
Based on component, the Perfusion Systems in market is segmented into perfusion pumps, oxygenators, heart-lung machines, monitoring systems, cannulas, others. Oxygenators segment is anticipated to grow at a CAGR of 4.4% during the forecast period.
The Perfusion Systems market players are adopting the product launch and expansion strategies to cater to changing customer demands worldwide, which also allows them to maintain their brand name globally.
Perfusion Systems Market Report Scope
Perfusion Systems Market – by Type
- Microfluidic Perfusion Systems
- Small-Mammal Organ Perfusion Systems
- Bioreactor Perfusion Systems
- Gravity or Pressure-Driven Perfusion Systems
Perfusion Systems Market – by Component
- Perfusion Pumps
- Oxygenators
- Heart-Lung Machines
- Monitoring Systems
- Cannulas
- Others
Perfusion Systems Market – by Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of APAC
Middle East & Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of MEA
South America and Central America (SCAM)
- Brazil
- Argentina
- Rest of SCAM
Company Profiles
- REPLIGEN CORPORATION
- Merck KGaA
- Ala Scientific Instruments, Inc.
- XVIVO Perfusion
- Medtronic
- XENIOS AG (Fresenius Medical Care AG & Co. KGaA)
- Getinge AB
- TERUMO CORPORATION
- LivaNova PLC
- Sartorius AG
- Harvard Bioscience
- RAND
- Sanisure (Sani-Tech West, Inc.)
- AutoMate Scientific, Inc
- Jobst Technologies GmbH
- APD (Advanced Perfusion Diagnostics)
- Spectrum Medical, Transonic Systems Inc
- OrganOx
- ISCHEMAVIEW, INC
- CESCO BIOENGINEERING CO., LTD
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type ; Component and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
US, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
1. INTRODUCTION
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 market segmentation
1.3.1 Global Perfusion Systems Market – By Type
1.3.2 Global Perfusion Systems Market – By Component
1.3.3 Global Perfusion Systems Market – By Geography
2. Global Perfusion systems market – Key takeaways
3. research Methodology
3.1.1 Coverage
3.1.2 Secondary Research
3.1.3 Primary Research
4. Global Perfusion systems market – market landscape
4.1 overview
4.2 pest analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe– PEST Analysis
4.2.3 Asia Pacific– PEST Analysis
4.2.4 Middle East & South Africa– PEST Analysis
4.2.5 South and Central America – PEST Analysis
5. Global perfusion systems market – Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Rising Prevalence of Cardiovascular Diseases
5.1.2 Significant Growth of Pharmaceutical and Biotechnology Industries
5.1.3 Rising Need for The Organ Transplantation
5.1.4 Rising Cell Based Research Activities
5.2 Key Market Challenges
5.2.1 Expensive Organ Transplant Surgeries
5.2.2 Limited Numbers of Donors for Organ Transplant Surgeries
5.3 Key Market Opportunities
5.3.1 Growth Opportunities in Emerging Regions
5.4 Impact analysis
6. Perfusion Systems market – Global Analysis
6.1 global Perfusion Systems market Revenue Forecasts and Analysis
6.2 global Perfusion systems market, By Geography - Forecasts and Analysis
6.3 PERFORMANCE OF KEY PLAYERS
6.3.1 Getinge AB
6.3.2 Medtronic
6.4 expert opinions
7. Global Perfusion Systems Market analysis– by type
7.1 overview
7.2 Global Perfusion Systems Market BY Type, 2018 & 2027 (%)
7.3 Microfluidic perfusion systems Market
7.3.1 Overview
7.3.2 Global Microfluidic Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 Small-Mammal Organ perfusion systems market
7.4.1 Overview
7.4.2 Global Small-Mammal Organ Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 bioreactors perfusion systems maRKET
7.5.1 Overview
7.5.2 Global Bioreactors Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
7.6 gravity or pressure-driven perfusion systems maRKET
7.6.1 Overview
7.6.2 Global Gravity or Pressure-Driven Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
8. global perfusion systems Market analysis– by component
8.1 overview
8.2 Global perfusion systems Market, BY component 2018 & 2027 (%)
8.3 perfusion pumps market
8.3.1 Overview
8.3.2 Global Perfusion Pumps Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Oxygenators market
8.4.1 Overview
8.4.2 Global Oxygenators Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 heart lung Machine market
8.5.1 Overview
8.5.2 Global Heart-Lung Machine Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Monitoring Systems market
8.6.1 Overview
8.6.2 Global Monitoring Systems Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 Cannulas market
8.7.1 Overview
8.7.2 Global Cannulas Market Revenue and Forecasts to 2027 (US$ Mn)
8.8 Others market
8.8.1 Overview
8.8.2 Global Others Market Revenue and Forecasts to 2027 (US$ Mn)
9. Perfusion SYstems MARKET REVENUE AND FORECASTS TO 2027 – GEOGRAPHICAL ANALYSIS
9.1 north america Perfusion Systems market
9.1.1 Overview
9.1.2 North America Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.3 North America Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.4 North America Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
9.1.5 North America Perfusion Systems Market Revenue and Forecasts to 2027, By Country (%)
9.1.6 US Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.7 US Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.7.1 US Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.7.2 US Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
9.1.8 Canada Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.9 Canada Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.9.1 Canada Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.9.2 Canada Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
9.1.10 Mexico Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.11 Mexico Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.11.1Mexico Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.11.2Mexico Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
9.2 Europe Perfusion SYstems market
9.2.1 Overview
9.2.2 Europe Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.3 Europe Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.2.4 Europe Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
9.2.5 Europe Perfusion Systems Market Revenue and Forecasts to 2027, By Country (%)
9.2.6 Germany Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.7 Germany Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.7.1 Germany Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.2.7.2 Germany Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
9.2.8 UK Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.9 UK Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.9.1 UK Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.2.9.2 UK Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
9.2.10 France Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.11 France Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.11.1France Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.2.11.2France Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
9.2.12 Spain Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.13 Spain Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.13.1Spain Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.2.13.2Spain Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
9.2.14 Italy Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.15 Italy Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.15.1Italy Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.2.15.2Italy Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
9.3 ASIA Pacific perfusion systems MARKET
9.3.1 Overview
9.3.2 Asia Pacific Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.3 Asia Pacific Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.3.4 Asia Pacific Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
9.3.5 Asia Pacific Perfusion Systems Market Revenue and Forecasts to 2027, By Country (%)
9.3.6 China Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.7 China Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.7.1 China Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.3.7.2 China Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
9.3.8 Japan Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.9 Japan Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.9.1 Japan Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.3.9.2 Japan Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
9.3.10 India Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.11 India Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.11.1India Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.3.11.2India Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
9.3.12 Australia Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.13 Australia Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.13.1Australia Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.3.13.2Australia Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
9.3.14 South Korea Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.15 South Korea Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.15.1South Korea Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.3.15.2South Korea Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
9.4 Middle East & Africa Perfusion Systems market
9.4.1 Middle East & Africa Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.4.2 Middle East & Africa Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.4.3 Middle East & Africa Perfusion Systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)
9.4.4 Middle East & Africa Perfusion Systems Market Revenue and Forecasts to 2027, By Country (%)
9.4.5 UAE Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.4.6 UAE Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.4.6.1 UAE Perfusion Systems Market Revenue and Forecasts to 2027,By Type (US$ Mn)
9.4.6.2 UAE Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
9.4.7 Saudi Arabia Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.4.8 Saudi Arabia Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.4.8.1 Saudi Arabia Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.4.8.2 Saudi Arabia Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
9.4.9 South Africa Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.4.10 South Africa Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.4.10.1. South Africa Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.4.10.2. South Africa Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
9.5 SOUTH AND CENTRAL AMERICA PERFUSION SYSTEMS MARKET
9.5.1 Overview
9.5.2 South and Central America Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.5.3 South and Central America Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.5.4 South and Central America Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
9.5.5 South and Central America Perfusion Systems Market Revenue and Forecasts to 2027, By Country (%)
9.5.6 Brazil Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.5.7 Brazil Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.5.7.1 Brazil Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.5.7.2 Brazil Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
9.5.8 Argentina Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.5.9 Argentina Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
9.5.9.1 Argentina Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.5.9.2 Argentina Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
10. PERFUSION SYSTEMS MARKET –Industry Landscape
10.1 Overview
10.2 Growth Strategies in the perfusion systems Market, 2015-2018
10.3 Organic Developments
10.3.1 Overview
10.4 Organic Growth Strategies in the perfusion systems Market, 2016-2018
10.5 Product Approval
10.5.1 Recent Product Approval by Players in the Perfusion Systems Market, 2015-2018
10.6 Product Launch
10.6.1 Recent Product Launch by Players in the Perfusion Systems Market, 2015-2018
10.7 Others
10.7.1 Others Organic Strategies Made by the Players in the Perfusion Systems Market, 2015-2018
10.8 Inorganic developments
10.8.1 Overview
10.9 inOrganic Growth Strategies in the perfusion systems Market,
2015-2018
10.10 Acquisition
10.10.1 Acquisition Made by the Players in the perfusion systems Market, 2015-2018
10.11 Partnerships
10.11.1 Recent Partnership by Players in the Perfusion Systems Market, 2015-2018
10.12 Collaboration
10.12.1 Collaboration by Players in the Perfusion Systems Market, 2015-2018
10.13 Agreement
10.13.1 Agreement Made by the Players in the Perfusion Systems Market, 2015-2018
11. Perfusion Systems Market–Key company profiles
11.1 Existing Players
11.1.1 REPLIGEN CORPORATION
11.1.1.1 Key Facts
11.1.1.2 Business Description
11.1.1.3 Financial Overview
11.1.1.4 Product Portfolio
11.1.1.5 SWOT Analysis
11.1.1.6 Key Developments
11.1.2 Merck KGaA
11.1.2.1 Key Facts
11.1.2.2 Business Description
11.1.2.3 Financial Overview
11.1.2.4 Product Portfolio
11.1.2.5 SWOT Analysis
11.1.2.6 Key Developments
11.1.3 ALA Scientific Instruments, Inc.
11.1.3.1 Key Facts
11.1.3.2 Business Description
11.1.3.3 Financial Overview
11.1.3.4 Product Portfolio
11.1.3.5 SWOT Analysis
11.1.3.6 Key Developments
11.1.4 XVIVO Perfusion
11.1.4.1 Key Facts
11.1.4.2 Business Description
11.1.4.3 Financial Information
11.1.4.4 Product Portfolio
11.1.4.5 SWOT Analysis
11.1.4.6 Key Developments
11.1.5 Medtronic
11.1.5.1 Key Facts
11.1.5.2 Business Description
11.1.5.3 Financial Information
11.1.5.4 Product Portfolio
11.1.5.5 SWOT Analysis
11.1.5.6 Key Developments
11.1.6 XENIOS AG (Fresenius Medical Care AG & Co. KGaA)
11.1.6.1 Key Facts
11.1.6.2 Business Description
11.1.6.3 Financial Information
11.1.6.4 Product Portfolio
11.1.6.5 SWOT Analysis
11.1.6.6 Key Developments
11.1.7 TERUMO CORPORATION
11.1.7.1 Key Facts
11.1.7.2 Business Description
11.1.7.3 Financial Overview
11.1.7.4 Product Portfolio
11.1.7.5 SWOT Analysis
11.1.7.6 Key Developments
11.1.8 Getinge AB
11.1.8.1 Key Facts
11.1.8.2 Business Description
11.1.8.3 Financial Overview
11.1.8.4 Product Portfolio
11.1.8.5 SWOT Analysis
11.1.8.6 Key Developments
11.1.9 Harvard Bioscience
11.1.9.1 Key Facts
11.1.9.2 Business Description
11.1.9.3 Financial Overview
11.1.9.4 Product Portfolio
11.1.9.5 SWOT Analysis
11.1.9.6 Key Developments
11.1.10 OrganOx
11.1.10.1Key Facts
11.1.10.2Business Description
11.1.10.3Financial Overview
11.1.10.4Product Portfolio
11.1.10.5SWOT Analysis
11.1.10.6Key Developments
11.2 Emerging Players
11.2.1 Sartorius AG
11.2.1.1 Key Facts
11.2.1.2 Business Description
11.2.1.3 Financial Overview
11.2.1.4 Product Portfolio
11.2.1.5 SWOT Analysis
11.2.1.6 Key Developments
11.2.2 RAND
11.2.2.1 Key Facts
11.2.2.2 Business Description
11.2.2.3 Financial Overview
11.2.2.4 Product Portfolio
11.2.2.5 SWOT Analysis
11.2.2.6 Key Developments
11.2.3 LivaNova PLC
11.2.3.1 Key Facts
11.2.3.2 Business Description
11.2.3.3 Financial Overview
11.2.3.4 Product Portfolio
11.2.3.5 SWOT Analysis
11.2.3.6 Key Developments
11.2.4 Sanisure (Sani-Tech West, Inc.)
11.2.4.1 Key Facts
11.2.4.2 Business Description
11.2.4.3 Financial Overview
11.2.4.4 Product Portfolio
11.2.4.5 SWOT Analysis
11.2.4.6 Key Developments
11.2.5 AutoMate Scientific, Inc.
11.2.5.1 Key Facts
11.2.5.2 Business Description
11.2.5.3 Financial Overview
11.2.5.4 Product Portfolio
11.2.5.5 SWOT Analysis
11.2.5.6 Key Developments
11.2.6 APD (Advanced Perfusion Diagnostics)
11.2.6.1 Key Facts
11.2.6.2 Business Description
11.2.6.3 Financial Overview
11.2.6.4 Product Portfolio
11.2.6.5 SWOT Analysis
11.2.6.6 Key Developments
11.2.7 Spectrum Medical
11.2.7.1 Key Facts
11.2.7.2 Business Description
11.2.7.3 Financial Overview
11.2.7.4 Product Portfolio
11.2.7.5 SWOT Analysis
11.2.7.6 Key Developments
11.2.8 Transonic Systems Inc.
11.2.8.1 Key Facts
11.2.8.2 Business Description
11.2.8.3 Financial Overview
11.2.8.4 Product Portfolio
11.2.8.5 SWOT Analysis
11.2.8.6 Key Developments
11.2.9 ISCHEMAVIEW, INC
11.2.9.1 Key Facts
11.2.9.2 Business Description
11.2.9.3 Financial Overview
11.2.9.4 Product Portfolio
11.2.9.5 SWOT Analysis
11.2.9.6 Key Developments
11.2.10 CESCO BIOENGINEERING CO., LTD.
11.2.10.1Key Facts
11.2.10.2Business Description
11.2.10.3Financial Overview
11.2.10.4Product Portfolio
11.2.10.5SWOT Analysis
11.2.10.6Key Developments
11.2.11 Jobst Technologies GmbH
11.2.11.1Key Facts
11.2.11.2Business Description
11.2.11.3Financial Overview
11.2.11.4Product Portfolio
11.2.11.5SWOT Analysis
11.2.11.6Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
LIST OF TABLES
TABLE 1. North America Perfusion Systems Market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 2. North America perfusion systems Market Revenue And Forecasts to 2027, By component (US$ Mn)
TABLE 3. US Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 4. US perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)
TABLE 5. Canada Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 6. Canada perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)
TABLE 7. Mexico Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 8. Mexico perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)
TABLE 9. Europe Perfusion Systems Market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 10. Europe perfusion systems Market Revenue And Forecasts to 2027, By component (US$ Mn)
TABLE 11. Germany Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 12. Germany perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)
TABLE 13. UK Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 14. UK perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)
TABLE 15. France Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 16. France perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)
TABLE 17. Spain Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 18. Spain perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)
TABLE 19. Italy Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 20. Italy perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)
TABLE 21. Asia Pacific Perfusion Systems Market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 22. Asia Pacific perfusion systems Market Revenue And Forecasts to 2027, By component (US$ Mn)
TABLE 23. China Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 24. China perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)
TABLE 25. Japan Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 26. Japan perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)
TABLE 27. India Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 28. India perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)
TABLE 29. Australia Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 30. Australia perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)
TABLE 31. South Korea Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 32. South Korea perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)
TABLE 33. Middle East & Africa Perfusion Systems Market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 34. Middle East & Africa perfusion systems Market Revenue And Forecasts to 2027, By component (US$ Mn)
TABLE 35. UAE Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 36. UAE perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)
TABLE 37. Saudi Arabia Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 38. Saudi Arabia perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)
TABLE 39. South Africa Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 40. South Africa perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)
TABLE 41. South and Central America Perfusion Systems Market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 42. South and Central America perfusion systems Market Revenue And Forecasts to 2027, By component (US$ Mn)
TABLE 43. Brazil Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 44. Brazil perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)
TABLE 45. Argentina Perfusion Systems Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 46. Argentina perfusion systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)
TABLE 47. Recent Product approval By Players in the perfusion systems Market, 2015-2018
TABLE 48. Recent Product Launch By Players in the perfusion systems Market, 2015-2018
TABLE 49. Others Organic Strategies Made by the Players in the Perfusion Systems Market, 2015-2018
TABLE 50. Acquisition made by the players in the perfusion systems market, 2015-2018
TABLE 51. Recent Partnership in the perfusion systems Market, 2015-2018
TABLE 52. Collaboration in the perfusion systems Market, 2015-2018
TABLE 53. Agreement made by the players in the Perfusion Systems market, 2015-2018
TABLE 54. Glossary of Terms, Perfusion systems market
LIST OF FIGURES
FIGURE 1. Perfusion Systems market Segmentation
FIGURE 2. perfusion systems Segmentation, by region
FIGURE 3. Asia Pacific Perfusion systems market, Revenue (US$ Mn), By Geography 2018 & 2027
FIGURE 4. Global Perfusion systems market By Type, Market Share (%), 2018
FIGURE 5. Global Perfusion systems market By Component, Market Share (%), 2018
FIGURE 6. North America PEST Analysis
FIGURE 7. Europe PEST Analysis
FIGURE 8. Asia pacific PEST Analysis
FIGURE 9. Middle East & South Africa PEST Analysis
FIGURE 10. South and central america PEST Analysis
FIGURE 11. perfusion systems market impact analysis of driver and Challenges
FIGURE 12. global Perfusion Systems market – Revenue Forecasts and Analysis –2018- 2027
FIGURE 13. global Perfusion systems market – by geography Forecasts and Analysis – 2018- 2027
FIGURE 14. Global Perfusion systems Market, by Type 2018 & 2027 (%)
FIGURE 15. Global Microfluidic Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 16. Global Small-Mammal Organ Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 17. Global Bioreactors perfusion systems Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 18. Global Gravity Or Pressure-Driven Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 19. global perfusion systems Market, by component 2018 & 2027 (%)
FIGURE 20. global perfusion pumps Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 21. global Oxygenators Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 22. global heart-lung machine Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 23. global monitoring systems Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 24. global Cannulas Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 25. global others Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 26. North America Perfusion SYstems Market revenue Overview, by Country (2017) (us $ mn)
FIGURE 27. North America Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 28. North America perfusion systems Market Revenue And Forecasts to 2027, By Country (%)
FIGURE 29. US Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 30. Canada Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 31. Mexico Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 32. Europe Perfusion SYstems Market revenue Overview, by Country (2017) (us $ mn)
FIGURE 33. Europe Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 34. Europe perfusion systems Market Revenue And Forecasts to 2027, By Country (%)
FIGURE 35. Germany Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 36. UK Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 37. France Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 38. Spain Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 39. Italy Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 40. Asia Pacific Perfusion SYstems Market revenue Overview, by Country (2017) (us $ mn)
FIGURE 41. Asia Pacific Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 42. Asia Pacific perfusion systems Market Revenue And Forecasts to 2027, By Country (%)
FIGURE 43. China Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 44. Japan Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 45. India Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 46. Australia Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 47. South Korea Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 48. Middle East & Africa Perfusion SYstems Market revenue Overview, by Country (2017) (us $ mn)
FIGURE 49. Middle East & Africa Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 50. Middle East & Africa perfusion systems Market Revenue And Forecasts to 2027, By Country (%)
FIGURE 51. UAE Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 52. Saudi Arabia Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 53. South Africa Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 54. South and Central America Perfusion SYstems Market revenue Overview, by Country (2017) (us $ mn)
FIGURE 55. South and Central America Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 56. South and Central America perfusion systems Market Revenue And Forecasts to 2027, By Country (%)
FIGURE 57. Brazil Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 58. Argentina Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 59. Growth Strategies in the perfusion systems Market, 2015-2018
FIGURE 60. Organic Growth Strategies in the perfusion systems Market, 2016-2018
FIGURE 61. Inorganic developments in the perfusion systems Market, 2015-2018
The List of Companies - Perfusion Systems Market
- REPLIGEN CORPORATION
- Merck KGaA
- Ala Scientific Instruments, Inc.
- XVIVO Perfusion
- Medtronic
- XENIOS AG (Fresenius Medical Care AG & Co. KGaA)
- TERUMO CORPORATION
- Getinge AB
- Harvard Bioscience
- OrganOx
Emerging Players
- Sartorius AG
- RAND
- LivaNova PLC
- Sanisure (Sani-Tech West, Inc.)
- AutoMate Scientific, Inc.
- APD (Advanced Perfusion Diagnostics)
- Spectrum Medical
- Transonic Systems Inc
- CESCO BIOENGINEERING CO., LTD.
- Jobst Technologies GmbH
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For